Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H16F7N5O3 |
InChIKeyOTPOPNFYEGYICX-ZYHUDNBSSA-N |
CAS Registry2276680-91-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | JP | 29 Jul 2021 |